SOPHiA GENETICS

SOPHiA GENETICS Announces Two Million Patient Cases Analyzed—A New Milestone for #DataDrivenMedicine! Yesterday at NVIDIA GTC, Jurgi Camblong, our Co-founder and CEO, took the stage to unveil a breakthrough: over 2 million patient genomic profiles analyzed. This historic milestone reflects the growing global impact of AI-powered precision medicine, with 800+ institutions across 72 countries leveraging the SOPHiA DDM™ Platform to drive real-world impact in oncology and rare diseases. Our customers are at the heart of this success. We are honored to empower them: 💬 "We have been using the SOPHiA DDM™ Platform for nearly 10 years. Thanks to SOPHiA DDM™, the analysis of patients with hereditary cardiac pathologies at the second-largest university hospital in France is now faster and more efficient than ever. The Platform’s ease of use significantly enhances our ability to provide timely and accurate results. Thank you for empowering our institution to make an impact on countless lives among the two million genomic analyses,” said Gilles MILLAT, Gilles, University Lecturer, Hospital Practitioner, Hospices Civils de Lyon - HCL, France. 💬  “Huge congratulations to SOPHiA GENETICS for reaching the incredible milestone of two million genomic analyses! Working together, we’ve brought advanced cancer diagnostics to more patients across India, including those in underserved communities. With the SOPHiA DDM™ Platform, we’ve strengthened our ability to generate evidence and world-class research for faster and more accurate diagnosis, and we hope to expand it further in the coming years," added Dr. R.Venkataramanan, Founder, Karkinos Healthcare, India. The technology enables more effective and accurate treatment selection for cancer patients, at-scale: “SOPHiA DDM™ allows us to tackle a wide range of genetic analyses at Fondazione Policlinico Universitario Agostino Gemelli, from exome sequencing to hereditary cancer and HRD testing, without compromising accuracy or efficiency,” explains Dr. Angelo Minucci, Head of Molecular and Genomic Diagnostics Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Rome, Italy.  "With SOPHiA DDM™, we have been able to confidently identify genetic rearrangements that provide critical insights into the complexity of cancer,” said Dr. Jessica Van Ziffle, Associate Professor, Department of Pathology & Associate Director, UCSF Clinical Cancer Genomics Lab, United States. 🌍 On this special occasion, we want to thank our partners from around the world. Their expertise and dedication are shaping our collective journey. Throughout the month, we will be sharing their experiences—stay tuned for more impactful stories! 🔗 Visit our website to read the full announcement and our co-founders’ reflections: https://lnkd.in/d7PRYypW Lars Steinmetz | Hutter Pierre #Media #Investors #BreakingNews #AIinHealthcare

At SOPHiA GENETICS, we believe in the power of data to drive impact—but just as importantly, we believe in the power of people to create positive change. Today, on World Down Syndrome Day, we stand alongside our colleague John Carey, MBA and his beautiful daughter, Isla Rose, whose journey has touched and inspired our team. John has helped raise awareness within SOPHiA GENETICS about the importance of advocacy, inclusion, and better healthcare. His passion reminds us why our mission—leveraging data-driven medicine to improve lives—matters beyond technology. This week at #ACMGMtg25, our team is not only showcasing our latest innovations but also proudly wearing our crazy socks to celebrate the uniqueness that makes every individual special. 💙💛 To Isla Rose and the entire Down syndrome community—today, we stand with you in raising awareness and celebrating diversity. #WorldDownSyndromeDay #LotsOfSocks #TeamCulture #WeCare #ACMG25

Our customers' stories and voices are the true measure of our impact. Every milestone highlights the groundbreaking work across our global network. Celebrating 2 million patient cases analyzed is possible thanks to world-class healthcare institutions such as Fondazione Policlinico Universitario Agostino Gemelli IRCCS, one of over 800 advancing data-driven medicine with SOPHiA GENETICS. Their commitment to innovation and precision medicine is driving real impact. We are honored to continue collaborating and transforming healthcare together! Dr. Angelo Minucci #DataDrivenMedicine #AIinHealthcare

Have you met the best team in town? Come find us at #ACMGMtg25, booth #322. Learn how SOPHiA GENETICS is streamlining genomic complexity with our AI-powered platform and setting new standards for germline variant analysis in hereditary cancer and exome applications. #ACMG2025 #DataDrivenMedicine #AIinHealthcare ACMG - American College of Medical Genetics and Genomics

🇳🇱 Day 1 at the Clinical Cancer Genomics Congress in Amsterdam! 🧬 💡Join our team at KIT Amsterdam today and tomorrow and learn more about how SOPHiA GENETICS is empowering over 800 healthcare institutions worldwide streamline their genetic workflows leveraging the power of the SOPHiA DDM™ Platform. We can't wait to welcome you! #CCG2025 #ClinicalCancerGenomics #DataDrivenMedicine

🚀 Don't miss the next session in the Precision Oncology Showcase! Decentralizing a genomic assay is no small feat, but together with Memorial Sloan Kettering Cancer Center (MSK), we’ve made it possible. The decentralized version of MSK-ACCESS® on the SOPHiA DDM™ Platform delivers exceptional performance—validated by both internal studies and real-world data from six early adopter sites. Join us on March 26 at 10 am EST | 4 PM CET for an insightful webinar where we’ll reveal: 📊 Internal verification results demonstrating high concordance 🌍 How six early adopter sites successfully implemented this solution 🧬 How decentralized testing is advancing precision oncology and improving variant calling Register here: https://loom.ly/Bqt1g4E #PrecisionOncology #Genomics #LiquidBiopsy #NGS #OncologyInnovation #DataDrivenMedicine

Today marks a turning point for data-driven medicine: 2 million (and counting!) patient cases analyzed. 2 million times data empowered healthcare providers with life-changing insights. With each analysis, our global intelligence network gets smarter, making precision medicine a reality—regardless of location. What does this mean for the future of healthcare? Read my reflections.

What incredible momentum at NVIDIA GTC! The energy and enthusiasm around Jurgi Camblong's talk on #AIinHealthcare were truly remarkable—the room was beyond capacity, with hundreds of people attending. We are proud to see how much interest there is in how SOPHiA GENETICS has been pioneering AI-powered, data-driven medicine. Our Co-founder and CEO took the stage in front of a packed audience to share how #AI is transforming complex multimodal health data into actionable insights, accelerating precision medicine for patients worldwide. A big thank you to NVIDIA for the opportunity and to everyone who joined us—your engagement and passion are fueling the future of global health innovation. Exciting discussions are underway, and we can’t wait to share what’s next. Stay tuned! 🔗 Missed the live session? Jurgi’s talk is available on-demand: https://lnkd.in/dQVsayXb #GTC25 #MultimodalData #DataDrivenMedicine #HealthInnovation #PrecisionMedicine

⏳ Only 2 hours to go! Jurgi Camblong, SOPHiA GENETICS’ Co-founder and CEO, is about to take the stage at NVIDIA GTC to explore how AI is transforming health data into real-world impact. Don’t miss this session! 📍 In-Person at NVIDIA GTC 🕙 10:00 AM PDT 🔗 Can't make it live? The session will be available on-demand after 24 hours: https://lnkd.in/dQVsayXb #GTC25 #AIinHealthcare #DataDrivenMedicine #HealthEquity

📣 One day left! Don't miss our live webinar at Nature Research tomorrow! What you’ll learn: ➡️ Cutting-edge AI applications for germline research ➡️ Strategies to improve data accuracy, scalability, and speed ➡️ Real-world case studies of AI-driven workflows solving complex research challenges 🔗 Last chance to book your spot: https://loom.ly/e-MOezU #webinar #NatureResearch #genomics #precisionmedicine #AI